Clinical Trial

HRS-AKI Treatment With TIPS in Patients With Cirrhosis

Study acronym: Liver-HERO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 18, 2024 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
The study compares the effectiveness and safety of TIPS implantation in patients with HRS-AKI (stage1, 2 and 3) and liver cirrhosis with standard therapy (drug therapy with terlipressin + albumin).
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2022-04-20; most recent amendment 2024-11-14.
Status change: Not Yet Recruiting → Recruiting 2022-12-08
Trial Details
NCT Number NCT05346393
Lead Sponsor Jena University Hospital
Collaborators: German Research Foundation, University Hospital Halle (Saale)
Conditions Cirrhosis, Liver, Hepatorenal Syndrome, Acute Kidney Injury, Ascites Hepatic
Enrollment 124 participants
Start Date 2022-11-29
Primary Completion 2025-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2024-11-18